查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腫瘤血液學分子檢測市場與 COVID-19 影響分析，按產品類型、癌症類型、技術、最終用途、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1339883

腫瘤血液學分子檢測市場與 COVID-19 影響分析，按產品類型、癌症類型、技術、最終用途、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Onco-hematology Molecular Testing Market with COVID-19 Impact Analysis, By Product Type, By Cancer Type, By Technology, By End-use, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年，腫瘤血液學分子檢測市場規模為5.308億美元，2023年至2030年年複合成長率為13.3%。

腫瘤血液學分子檢測市場-市場動態：

  • 癌症病例發病率的上升和分子診斷測試的新進展可能會推動市場需求。
  • 全球癌症病例的患病率不斷上升，推動了診斷需求，這也推動了腫瘤血液學分子檢測市場的發展。此外，癌症病例導致對早期檢測和預防醫學的需求不斷成長。因此，這些因素穩步增加了腫瘤血液學分子檢測市場的需求。此外，隨著診斷測試最終用途的進步，腫瘤學分子診斷測試變得越來越流行。在癌症基因組測序、腫瘤模型、計算分析和創新的癌症研究方法中，正在進行大量的研究。然而，在癌症護理中，分子診斷測試的成本相對較高，並且根據治療類型的不同而有所不同，預計這將限制預測期內的市場成長。

腫瘤血液學分子檢測市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球腫瘤血液學分子檢測市場在預測期內（2023-2030 年）每年將以 13.3% 左右的年複合成長率成長
  • 由於醫療保健基礎設施數量的不斷增加和完善的醫療保健基礎設施，腫瘤血液學分子檢測行業預計將以顯著的速度成長
  • 基於技術細分，預計下一代測序將在 2022 年呈現最大市場佔有率
  • 從產品類型細分來看，2022年服務類型為主導
  • 按地區分類，亞太地區是 2022 年的主要收入來源

腫瘤血液學分子檢測市場-細分分析：

  • 全球腫瘤血液學分子檢測市場根據產品類型、癌症類型、技術、最終用途和地區進行細分。
  • 市場根據產品類型分為兩類：服務和檢測試劑盒和試劑。由於非霍奇金淋巴瘤、白血病和骨髓瘤的發病率不斷增加，服務領域可能會在預測期內保持其主導地位。此外，該細分市場的成長是由於人們對包括個性化藥物在內的多種治療方法的認知不斷提高而推動的。骨髓瘤診斷服務的不斷增加歸因於市場的成長。
  • 根據癌症類型，市場分為四類：肺癌、血液癌、乳腺癌、結直腸癌等。其他癌症領域的市場成長率最高。全球範圍內胃癌、前列腺癌和胰腺癌等各種癌症患病率的上升推動了該細分市場的成長。
  • 市場根據技術分為三類：qPCR、dPCR、新一代測序和其他。下一代測序領域可能擁有最大的收入佔有率。該技術提供的眾多優勢，包括特異性和更高的靈敏度，預計將推動該細分市場的成長。此外，下一代測序測試用於檢查診斷為淋巴細胞白血病的患者體內殘留的低水平癌細胞。 FDA 批准基於 NGS 的測試歸因於推動市場成長。
  • 根據最終用途，市場分為兩類：參考實驗室、醫院和其他。醫院部門預計將佔據最大的收入佔有率。癌症患者就診和診斷的人數不斷增加可能會推動這一成長。此外，由於上述因素，血癌發病率的上升、進行診斷測試和監測疾病的醫療保健專業人員的存在以及專業實驗室設施的可用性正在見證成長。

腫瘤血液學分子檢測市場-地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

腫瘤血液學分子檢測市場-競爭格局：

不斷上漲的醫療保健成本和旨在改善癌症治療和診斷的政府舉措正在推動市場收入成長。世界各國政府正在資助新的癌症診斷設備和治療方案的開發。此外，癌症發病率的增加、定製藥物需求的增加以及測試方法的技術發展是推動市場收入成長的一些主要驅動力。市場參與者正致力於通過採取技術網路開發、合併、研發活動和協作等多種策略來加強其業務。例如，2022 年 6 月，燃石生物科技有限公司宣布，其在美國和中國工廠生產的 OverC (TM) 多種癌症檢測血液測試已獲得 CE 標誌

最近的發展：

例如，2021年5月，羅氏與GenMark Diagnostics簽訂合併協議，羅氏將完全收購GenMark。此外，羅氏還計劃通過此次收購，利用 GenMark 在綜合症檢測方面的專業知識來擴大其分子診斷產品組合。

該研究的主要特點：

  • 這項關於腫瘤血液學分子檢測市場的研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年。
  • 該報告為客戶提供了有關腫瘤血液學分子檢測市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了腫瘤血液學分子檢測市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、現有參與者面臨的挑戰以及維持腫瘤血液學分子檢測市場的成長因素。
  • 研究範圍詳細討論了 COVID-19 對腫瘤血液學分子檢測市場規模、預測、年複合成長率和市場動態的影響。還將涵蓋對新冠疫情后腫瘤血液學分子檢測市場的詳細見解。
  • 為了讓本報告的用戶全面了解腫瘤血液學分子檢測市場，我們還對腫瘤血液學分子檢測市場的競爭格局和關鍵創新者進行了分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解在腫瘤血液學分子檢測市場中營運的參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球腫瘤血液學分子檢測市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和金融分析師。

目錄

第 1 章：腫瘤血液學分子檢測市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的腫瘤血液學分子檢測市場片段
    • 按癌症類型分類的腫瘤血液學分子檢測市場片段
    • 腫瘤血液學分子檢測市場技術片段
    • 按最終用途分類的腫瘤血液學分子檢測市場片段
    • 按國家/地區分類的腫瘤血液學分子檢測市場片段
    • 按地區分類的腫瘤血液學分子檢測市場片段
  • 競爭洞察

第 3 章：腫瘤血液學分子檢測主要市場趨勢

  • 腫瘤血液學分子檢測市場促進因素
    • 市場促進因素的影響分析
  • 腫瘤血液學分子檢測市場限制
    • 市場限制影響分析
  • 腫瘤血液學分子檢測市場機會
  • 腫瘤血液學分子檢測市場未來趨勢

第 4 章：腫瘤血液學分子檢測行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：腫瘤血液學分子檢測市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：腫瘤血液學分子檢測市場格局

  • 2022 年腫瘤血液學分子檢測市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：腫瘤血液學分子檢測市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 服務
    • 檢測試劑盒和試劑

第 8 章：腫瘤血液學分子檢測市場 - 按癌症類型

  • 概述
    • 按癌症類型分類的細分市場佔有率分析
    • 肺癌
    • 血液癌症
    • 乳癌
    • 結直腸癌
    • 其他

第 9 章：腫瘤血液學分子檢測市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 定量PCR
    • 聚合酶鍊式反應
    • 下一代測序
    • 其他

第 10 章：腫瘤血液學分子檢測市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 參考實驗室
    • 醫院
    • 其他

第 11 章：腫瘤血液學分子檢測市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 腫瘤血液學分子檢測北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按癌症類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲腫瘤血液學分子檢測主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按癌症類型）
    • 歐洲市場規模和預測（按技術）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區腫瘤血液學分子檢測主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按產品類型）
    • 亞太地區市場規模和預測（按癌症類型）
    • 亞太地區市場規模和預測（按技術）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲腫瘤血液學分子檢測主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按產品類型）
    • 拉丁美洲市場規模和預測（按癌症類型）
    • 拉丁美洲市場規模和預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 腫瘤血液學分子檢測中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按癌症類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析-腫瘤血液學分子檢測行業

  • 競爭儀表板
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • DiaSorin Molecular LLC
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Bayer AG
    • GenMark Diagnostics, Inc
    • Biocartis
    • BD
    • Agilent Technologies, Inc
    • QIAGEN
    • HTG Molecular Diagnostics, Inc.
    • Danaher Hologic, Inc.
    • BIOMERIEUX

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1607

REPORT HIGHLIGHT

Onco-hematology molecular testing market size was valued at USD 530.8 Million in 2022, expanding at a CAGR of 13.3% from 2023 to 2030.

Hematology molecular testing is the diagnostic procedure utilized in the field of hematological oncology to monitor and detect blood cancer and related disease. These tests play an essential role in the early diagnosis, treatment, and detection of hematological malignancies including myeloma, leukemia, and lymphoma. Moreover, it also involves numerous technologies such as flow cytometry, molecular testing, next-generation sequencing, and cytogenetics. In addition, these tests assist identify chromosomal abnormalities, genetic mutations, and other molecular markers associated with other types of blood cancers. By examining these makers healthcare professionals can make actual diagnoses, tailor treatment plans, and determine disease progression to individual patients.

Onco-hematology Molecular Testing Market- Market Dynamics:

  • The rising prevalence of cancer cases and new advancements in molecular diagnostics tests may propel the market demand.
  • The demand for diagnosis is driven by the increasing prevalence of cancer cases across the globe, which is fueling up the onco-hematology molecular testing market. Additionally, cancer cases are contributing to the growing requirement for early detection and preventive medicine. As a result, such factors increase the demand steadily for the onco-hematology molecular testing market. Moreover, molecular diagnostics tests for oncology are becoming more popular as diagnostic testing End-use advances. In cancer genome sequencing, tumor models, computational analysis, and innovative cancer research methods, numerous passages are being made. However, in cancer care, the cost of molecular diagnostic testing is comparably higher and it varies depending on the type of therapy which is expected to restrain the market growth over the forecast period.

Onco-hematology Molecular Testing Market- Key Insights:

  • As per the analysis shared by our research analyst, the global onco-hematology molecular testing market is estimated to grow annually at a CAGR of around 13.3% over the forecast period (2023-2030)
  • The onco-hematology molecular testing industry is projected to grow at a significant rate due to the growing number of healthcare infrastructure and well-established healthcare infrastructure
  • Based on technology segmentation, next-generation sequencing was predicted to show maximum market share in the year 2022
  • Based on product type segmentation, services was the leading type in 2022
  • On the basis of region, Asia-Pacific was the leading revenue generator in 2022

Onco-hematology Molecular Testing Market- Segmentation Analysis:

  • The global onco-hematology molecular testing market is segmented on the basis of product type, cancer type, technology, end-use, and region.
  • The market is divided into two categories based on product type: services and assay kits & reagents. The services segment is likely to maintain its dominance over the forecast period owing to its increasing incidence of non-Hodgkin lymphoma, leukemia, and myeloma. Additionally, the segment growth is driven by the increasing awareness regarding several treatment therapies including personalized medicines. The rising availability of services provided for the diagnosis of myeloma is attributed to boosting the growth of the market.
  • The market is divided into four categories based on cancer type: lung cancer, hematological cancer, breast cancer, colorectal cancer, and others. The other cancer segment is accounted to witness the highest growth rate in the market. The rise in the prevalence of various types of cancer such as gastric cancer, prostate cancer, and pancreas cancer globally propel the segment growth.
  • The market is divided into three categories based on technology: qPCR, dPCR, next-generation sequencing, and Others. The next-generation sequencing segment is likely to possess the largest revenue share. The numerous advantages provided by this technology including specificity and more sensitivity are expected to fuel the segment growth. Moreover, next-generation sequencing tests are utilized to examine low levels of cancer cells remaining in patients diagnosed with lymphoblastic leukemia. The FDA approvals for NGS-based tests are attributed to driving the market growth.
  • The market is divided into two categories based on end-use: reference laboratories, hospitals, and others. The hospital segment is expected to dominate the largest revenue share. The rising number of cancer patients' visits for treatment and diagnosis is likely to drive the growth. Moreover, the rise in the incidence rate of blood cancers, the presence of healthcare professionals to conduct diagnostic tests, & monitor the disease, and the availability of specialized laboratory settings is witnessing growth owing to above mention factors.

Onco-hematology Molecular Testing Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Onco-hematology Molecular Testing Market- Competitive Landscape:

Rising healthcare costs and government initiatives aimed at improving cancer treatment and diagnosis are driving market revenue growth. Governments across the world are funding the development of new cancer diagnostic equipment and treatment regimens. Moreover, increasing cancer occurrence, increased need for customized medication, and technical developments in testing methodologies are some of the primary drivers driving market revenue growth. Market players are focusing to strengthen their business by adopting several strategies such as technology network development, mergers, R&D activities, and collaboration. For instance, in June 2022, Burning Rock Biotech Limited introduced that it has received a CE marking for its OverC™ Multi-Cancer Detection Blood Test manufactured in both the US and China facilities

Recent Developments:

For instance, in May 2021, Roche and GenMark Diagnostics entered into a merger agreement in which Roche will fully acquire GenMark. Additionally, Roche aims to expand its portfolio of molecular diagnostics with GenMark's expertise in syndromic testing through the acquisition.

Key features of the study:

  • This proposed research study on onco-hematology molecular testing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the onco-hematology molecular testing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for onco-hematology molecular testing market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the onco-hematology molecular testing market.
  • Impact of COVID-19 on onco-hematology molecular testing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on onco-hematology molecular testing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the onco-hematology molecular testing market, we have also included competitive landscape and key innovator analysis for the onco-hematology molecular testing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the onco-hematology molecular testing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global onco-hematology molecular testing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd
  • DiaSorin Molecular LLC
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Bayer AG
  • GenMark Diagnostics, Inc
  • Biocartis
  • BD
  • Agilent Technologies, Inc
  • QIAGEN
  • HTG Molecular Diagnostics, Inc.
  • Danaher Hologic, Inc.
  • BIOMERIEUX

GLOBALONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY PRODUCT TYPE

  • Services
  • Assay Kits & Reagents

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY CANCER TYPE

  • Lung Cancer
  • Hematological Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Other

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY TECHNOLOGY

  • qPCR
  • dPCR
  • Next-Generation Sequencing
  • Others

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY END-USE

  • Reference Laboratories
  • Hospitals
  • Others

GLOBAL ONCO-HEMATOLOGY MOLECULAR TESTING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Onco-hematology Molecular Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Onco-hematology Molecular Testing Market Snippet by Product Type
    • 2.1.2. Onco-hematology Molecular Testing Market Snippet by Cancer Type
    • 2.1.3. Onco-hematology Molecular Testing Market Snippet by Technology
    • 2.1.4. Onco-hematology Molecular Testing Market Snippet by End-use
    • 2.1.5. Onco-hematology Molecular Testing Market Snippet by Country
    • 2.1.6. Onco-hematology Molecular Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Onco-hematology Molecular Testing Key Market Trends

  • 3.1. Onco-hematology Molecular Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Onco-hematology Molecular Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Onco-hematology Molecular Testing Market Opportunities
  • 3.4. Onco-hematology Molecular Testing Market Future Trends

4. Onco-hematology Molecular Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Onco-hematology Molecular Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Onco-hematology Molecular Testing Market Landscape

  • 6.1. Onco-hematology Molecular Testing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Onco-hematology Molecular Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Services
    • 7.1.3. Assay Kits & Reagents

8. Onco-hematology Molecular Testing Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2022&2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Hematological Cancer
    • 8.1.4. Breast Cancer
    • 8.1.5. Colorectal Cancer
    • 8.1.6. Other

9. Onco-hematology Molecular Testing Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2022&2030 (%)
    • 9.1.2. qPCR
    • 9.1.3. dPCR
    • 9.1.4. Next-Generation Sequencing
    • 9.1.5. Others

10. Onco-hematology Molecular Testing Market - By End-use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
    • 10.1.2. Reference Laboratories
    • 10.1.3. Hospitals
    • 10.1.4. Others

11. Onco-hematology Molecular Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Onco-hematology Molecular Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Onco-hematology Molecular Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Onco-hematology Molecular Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Onco-hematology Molecular Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Onco-hematology Molecular Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Onco-hematology Molecular Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche Ltd
    • 12.2.2. DiaSorin Molecular LLC
    • 12.2.3. Abbott
    • 12.2.4. Thermo Fisher Scientific Inc.
    • 12.2.5. Bayer AG
    • 12.2.6. GenMark Diagnostics, Inc
    • 12.2.7. Biocartis
    • 12.2.8. BD
    • 12.2.9. Agilent Technologies, Inc
    • 12.2.10. QIAGEN
    • 12.2.11. HTG Molecular Diagnostics, Inc.
    • 12.2.12. Danaher Hologic, Inc.
    • 12.2.13. BIOMERIEUX

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Onco-hematology Molecular Testing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Onco-hematology Molecular Testing Market, by Product Type2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Cancer TypeSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Onco-hematology Molecular Testing Market, by Cancer Type2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Onco-hematology Molecular Testing Market, by Technology 2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: End-use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Onco-hematology Molecular Testing Market, by End-use 2018-2030 (USD Million)
  • TABLE Onco-hematology Molecular Testing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Onco-hematology Molecular Testing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Onco-hematology Molecular Testing Market, by End-use, 2018-2030 (USD Million)

List of Figures

  • FIGURE Onco-hematology Molecular Testing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022&2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Cancer Type segment market share analysis, 2022&2030
  • FIGURE Cancer Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022&2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-use segment market share analysis, 2022&2030
  • FIGURE End-use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Onco-hematology Molecular Testing Market share and leading players, 2022
  • FIGURE Europe Onco-hematology Molecular Testing Market share and leading players, 2022
  • FIGURE Asia Pacific Onco-hematology Molecular Testing Market share and leading players, 2022
  • FIGURE Latin America Onco-hematology Molecular Testing Market share and leading players, 2022
  • FIGURE Middle East and Africa Onco-hematology Molecular Testing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Onco-hematology Molecular Testing Market share analysis by country, 2022
  • FIGURE Germany Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Onco-hematology Molecular Testing Market share analysis by country, 2022
  • FIGURE India Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Onco-hematology Molecular Testing Market share analysis by country, 2022
  • FIGURE Brazil Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Onco-hematology Molecular Testing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Onco-hematology Molecular Testing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)